BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 30138161)

  • 41. [Fecal microbiota transplantation through colonoscopy for Clostridium difficile recurrent infection. Report of eight cases].
    Quera R; Ibáñez P; Simian D; Rivera D; Acuña G; Espinoza R
    Rev Med Chil; 2018 Aug; 146(8):823-830. PubMed ID: 30534859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
    Furuya-Kanamori L; Doi SA; Paterson DL; Helms SK; Yakob L; McKenzie SJ; Garborg K; Emanuelsson F; Stollman N; Kronman MP; Clark J; Huber CA; Riley TV; Clements AC
    J Clin Gastroenterol; 2017 Feb; 51(2):145-150. PubMed ID: 26974758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.
    Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS
    Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Pardi DS; Bartlett MG; Khanna S
    Clin Infect Dis; 2019 Apr; 68(8):1351-1358. PubMed ID: 30957161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.
    Qazi T; Amaratunga T; Barnes EL; Fischer M; Kassam Z; Allegretti JR
    Gut Microbes; 2017 Nov; 8(6):574-588. PubMed ID: 28723262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

  • 50. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
    Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
    Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.
    Rubin TA; Gessert CE; Aas J; Bakken JS
    Anaerobe; 2013 Feb; 19():22-6. PubMed ID: 23182843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection.
    Feuerstadt P; Aroniadis OC; Svedlund FL; Garcia M; Stong L; Boules M; Khanna S
    Dig Dis Sci; 2022 Jul; 67(7):2763-2770. PubMed ID: 34275058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
    Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
    Chapman BC; Moore HB; Overbey DM; Morton AP; Harnke B; Gerich ME; Vogel JD
    J Trauma Acute Care Surg; 2016 Oct; 81(4):756-64. PubMed ID: 27648772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial experience with fecal microbiota transplantation in Clostridium difficile infection - transplant protocol and preliminary results.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Pinto-Pais T; Fernandes C; Ribeiro I; Rodrigues J; Lopes P; Teixeira T; Carvalho J
    Rev Esp Enferm Dig; 2015 Jul; 107(7):402-7. PubMed ID: 26140631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose.
    Allegretti JR; Fischer M; Sagi SV; Bohm ME; Fadda HM; Ranmal SR; Budree S; Basit AW; Glettig DL; de la Serna EL; Gentile A; Gerardin Y; Timberlake S; Sadovsky R; Smith M; Kassam Z
    Dig Dis Sci; 2019 Jun; 64(6):1672-1678. PubMed ID: 30519847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.